Internal Medicine, Rheumatology · Covington, LA
NPI
1649259789
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1000 Ochsner Blvd
Covington, LA, 70433
Phone (985) 875-2828
Groups this clinician bills Medicare through
Medicare paid, 2024
$47K
1,708 services
Medicare patients, 2024
336
Average age 69
Drug cost, 2024
$10.5M
18,653 prescriptions
Company payments, 2025
$7,181
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Malik C Spady was code 99215 (office e&m - established), 371 times for 264 patients. In total Malik C Spady billed 1,708 services in 17 codes, and Medicare paid $47K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Office | 371 | 264 | $94.01 | $35K |
| 99214 Office E&M - Established | Office | 146 | 118 | $69.64 | $10K |
By year: 2022 $54K for 619 services; 2023 $50K for 601 services; 2024 $47K for 1,708 services.
Medicare prescription drug claims, 2024
In 2024, the drug Malik C Spady prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 1,733 prescriptions and refills. In total Malik C Spady wrote 18,653 Medicare prescriptions that cost $10.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 1,733 | 1,733 | 242 | $42K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,143 | 1,143 | 131 | $33K |
| Prednisone Generic | 885 | 1,315 | 285 | $6,559 |
| Hydroxychloroquine Sulfate Generic | 881 | 1,714 | 248 | $32K |
| Tramadol Hcl Generic | 719 | 730 | 153 | $5,510 |
| Mounjaro Tirzepatide | 552 | 591 | 99 | $608K |
| Gabapentin Generic | 458 | 760 | 131 | $7,402 |
| Pregabalin Generic | 450 | 533 | 103 | $5,338 |
| Zolpidem Tartrate Generic | 358 | 410 | 54 | $1,224 |
| Ozempic Semaglutide | 333 | 383 | 60 | $349K |
| Fluconazole Generic | 310 | 327 | 152 | $5,467 |
| Alprazolam Generic | 219 | 219 | 47 | $679 |
| Tizanidine Hcl Generic | 200 | 318 | 63 | $2,830 |
| Levothyroxine Sodium Generic | 194 | 444 | 63 | $1,492 |
| Eszopiclone Generic | 182 | 198 | 41 | $2,099 |
Brand drugs: 3,042 claims; generic drugs: 15,532 claims; opioid claims: 3,720.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Malik C Spady $7,181 ($7,181 in general payments such as food, travel and fees) from 10 companies. The largest payer was Mallinckrodt Hospital Products Inc. with $5,615.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 13 | $5,615 |
| Abbvie Inc. ABBV | 33 | $503 |
| UCB, Inc. UCB.BR | 13 | $287 |
| Janssen Biotech, Inc. JNJ | 8 | $230 |
| Amgen Inc. AMGN | 10 | $206 |
| GlaxoSmithKline, LLC. GSK | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $94.39 |
| Aurinia Pharma U.S., Inc. AUPH | 4 | $85.04 |
| Genentech USA, Inc. ROG.SW | 1 | $18.17 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $17.5 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.